Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 30.70M | £ 33.20M | £ 35.40M | £ 8.80M | £ 42.60M |
Total Assets | £ 2.52B | £ 2.45B | £ 2.47B | £ 2.53B | £ 2.53B |
Total Debt | £ 1.62B | £ 1.66B | £ 1.64B | £ 1.63B | £ 1.68B |
Net Debt | £ 1.59B | £ 1.63B | £ 1.60B | £ 1.62B | £ 1.63B |
Total Liabilities | £ 1.87B | £ 2.00B | £ 2.06B | £ 2.05B | £ 2.28B |
Stockholders Equity | £ 648.10M | £ 451.80M | £ 406.40M | £ 480.70M | £ 248.90M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |